Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Curr Alzheimer Res

Retrieve available abstracts of 224 articles:
HTML format
Text format



Single Articles


    March 2017
  1. DOMINGUES C, da Cruz E Silva OA, Henriques AG
    Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks.
    Curr Alzheimer Res. 2017 Mar 17. doi: 10.2174/1567205014666170317113606.
    PubMed     Text format     Abstract available


  2. RODRIGUEZ-CASADO A, Toledano-Diaz A, Toledano A
    Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions.
    Curr Alzheimer Res. 2017 Mar 16. doi: 10.2174/1567205014666170316161848.
    PubMed     Text format     Abstract available


  3. POZA J, Gomez C, Garcia M, Tola-Arribas MA, et al
    Spatio-Temporal Fluctuations of Neural Dynamics in Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309115656.
    PubMed     Text format     Abstract available


  4. GARRE-OLMO J, Faundez-Zanuy M, Lopez-de-Ipina K, Calvo-Perxas L, et al
    Kinematic and pressure features of handwriting and drawing: preliminary results between patients with mild cognitive impairment, Alzheimer disease and healthy controls.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309120708.
    PubMed     Text format     Abstract available


  5. GARRARD P, Nemes V, Nikolic D, Barney A, et al
    Motif discovery in speech: Application to monitoring Alzheimer's disease.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309121025.
    PubMed     Text format     Abstract available


    February 2017
  6. SHARMA S, Lipincott W
    Biomarkers in Alzheimer's Disease-Recent Update.
    Curr Alzheimer Res. 2017 Feb 20. doi: 10.2174/1567205014666170220141822.
    PubMed     Text format     Abstract available


  7. KIM J, Fischer CE, Schweizer TA, Munoz DG, et al
    Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Feb 20. doi: 10.2174/1567205014666170220150021.
    PubMed     Text format     Abstract available


  8. NIXON DW
    The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism.
    Curr Alzheimer Res. 2017 Feb 16. doi: 10.2174/1567205014666170216152905.
    PubMed     Text format     Abstract available


  9. DE MARCO M, Vallelunga A, Meneghello F, Varma S, et al
    ApoE epsilon4 allele relateted alterations in hippocampal connectivity in early Alzheimer's disease support memory performance.
    Curr Alzheimer Res. 2017 Feb 6. doi: 10.2174/1567205014666170206113528.
    PubMed     Text format     Abstract available


  10. WU W, Xie S, Li B, Yang K, et al
    Protective effects of Huang-Lian-Jie-Du-Tang on Abeta25-35-induced memory deficits and oxidative stress in male rats.
    Curr Alzheimer Res. 2017 Feb 6. doi: 10.2174/1567205014666170206163158.
    PubMed     Text format     Abstract available


  11. NICOLIA V, Ciraci V, Cavallaro RA, Ferrer I, et al
    GSK3beta 5'-flanking DNA methylation and expression in Alzheimer's Disease patients.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203153325.
    PubMed     Text format     Abstract available


  12. LESZEK J, Tse WH, Zhang J, Avila-Rodriguez MF, et al
    Nanotechnology for Alzheimer Disease.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203125008.
    PubMed     Text format     Abstract available


  13. MANTZAVINOSA V, Alexiou A, Greig NH, Kamal MA, et al
    Biomarkers for Alzheimer's Disease Diagnosis.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203125942.
    PubMed     Text format     Abstract available


  14. AHMAD K, Baig MH, Mushtaq G, Kamal MA, et al
    Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer Disease and other neurodegenerative diseases: An in silico-updated overview.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203141151.
    PubMed     Text format     Abstract available


  15. REGEN F, Hellmann-Regen J, Costantini E, Reale M, et al
    Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203141717.
    PubMed     Text format     Abstract available


  16. SHACKLETON B, Crawford F, Bachmeier C
    Apolipoprotein E-mediated modulation of ADAM10 in Alzheimer's disease.
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203093219.
    PubMed     Text format     Abstract available


  17. CHHETRI J, King AE, Gueven N
    Alzheimer's Disease and NQO1: Is there a Link?
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203095802.
    PubMed     Text format     Abstract available


  18. COSTA IB, Labio RW, Rasmussen LT, Viani GA, et al
    Change in INSR, APBA2 and IDE Gene Expressions in Brains of Alzheimer s Disease Patients.
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203100734.
    PubMed     Text format     Abstract available


    January 2017
  19. DECOURT B, Drumm-Gurnee D, Wilson J, Jacobson S, et al
    Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's disease: Results from a Double-Blind, Placebo-Controlled Trial.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  20. FUKAMI Y, Ariga T, Yamada M, Yuki N, et al
    Brain gangliosides in Alzheimer's disease: Increased expression of cholinergic neuron-specific gangliosides.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  21. HULL M, Sadowsky C, Arai H, Le Prince Leterme G, et al
    Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  22. TERZIOGLU-USAK S, Negis Y, Karabulut DS, Zaim M, et al
    Cellular model of Alzheimer's disease: Abeta1-42 peptide induces amyloid deposition and a decrease in topo isomerase IIbeta and Nurr1 expression.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  23. KLIMOVA B, Kuca K
    Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review Alzheimer's Disease and Chinese Medicine.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  24. ANNA P, Federico S, Massimo V
    Resilience to Alzheimer's disease: the role of physical activity.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  25. KRANTIC S
    Editorial: From Current Diagnostic Tools and Therapeutics for Alzheimer's Disease Towards Earlier Diagnostic Markers and Treatment Targets.
    Curr Alzheimer Res. 2017;14:2-5.
    PubMed     Text format    


    December 2016
  26. BRUCKMANN S, Brenn A, Grube M, Niedrig K, et al
    Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  27. YU E, Liao Z, Mao D, Zhang Q, et al
    Directed functional connectivity of posterior cingulate cortex and whole brain in Alzheimer's disease and mild cognitive impairment.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  28. PU YZ, Liang L, Fu AL, Liu Y, et al
    Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation under Control of Zebrafish appb Promotor.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    November 2016
  29. MIRZA Z, Beg MA
    Molecular Interactions of Bexarotene - A Retinoid Drug And Alzheimer's Abeta Peptide: A Docking Study.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  30. ZHU R, Liu X, He Z
    Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer's Disease: An Updated Meta-analysis.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  31. ROUCH L, Cestac P, Cool C, Helmer C, et al
    Effectiveness of a standardized and specific follow-up in memory centers in patients with Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  32. IVACHTCHENKO AV, Ivanenkov YA, Veselov MS
    Preclinical evaluation of AVN-322, novel and highly selective 5-HT6 receptor antagonist, for the treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    October 2016
  33. SEIDL C, de Moraes Santos CA, De Simone A, Bartolini M, et al
    Uleine disrupts key enzymatic and non-enzymatic biomarkers that leads to Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  34. XU DS, Ponce F
    Deep Brain Stimulation for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  35. ZORZETTO M, Datturi F, Divizia L, Pistono C, et al
    Complement C4A and C4B gene copy number study in Alzheimer's disease patients.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  36. ARCE-VARAS N, Abate G, Prandelli C, Martinez C, et al
    Comparison of extracellular and intracellular blood compartments highlights redox alterations in Alzheimer's and Mild Cognitive Impairment patients.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  37. BOUTAJANGOUT A, Noorwali A, Atta H, Wisniewski T, et al
    Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    September 2016
  38. DECOURT B, Lahiri DK, Sabbagh MN
    Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  39. HSU D, Marshall GA
    Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  40. KAMKWALALA AR, Newhouse PA
    Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  41. GONSALVEZ I, Baror R, Fried P, Santarnecchi E, et al
    Therapeutic Noninvasive Brain Stimulation in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    August 2016

  42. Erratum: Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:1198.
    PubMed     Text format     Abstract available


  43. BUDNI J, Garcez ML, de Medeiros J, Cassaro E, et al
    The anti-inflammatory role of minocycline in Alzheimer s Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  44. CYNA M, Lynch M, Oore JJ, Nagy PM, et al
    The benefits of exercise and metabolic interventions for the prevention and early treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  45. VILLETTE V, Dutar P
    GABAergic microcircuits in Alzheimer's disease models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  46. MA K, McLaurin J
    alpha-Melanocyte Stimulating Hormone as a Potential Therapy for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  47. MONDRAGON-RODRIGUEZ S, Perry G, Pena-Ortega F, Williams S, et al
    Tau, Amyloid beta and Deep brain stimulation: Aiming to restore cognitive deficit in Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  48. REED BT, Behar-Cohen F, Krantic S
    Seeing early signs of Alzheimer's Disease through the lens of the eye.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  49. CHATTERJEE P, Roy D
    Insight into the epigenetics of Alzheimer's disease: A computational study from human interactome.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    July 2016
  50. DOURADO MC, Laks J
    Psychological Interventions for Neuropsychiatric Disturbances in Mild and Moderate Alzheimer's Disease: Current Evidences and Future Directions.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  51. SERAFINI G, Calcagno P, Lester D, Girardi P, et al
    Suicide Risk in Alzheimer's Disease: A Systematic Review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  52. LIAO Y, Qi XL, Cao Y, Yu WF, et al
    Elevations in the Levels of NF-kappaB and Inflammatory Chemotactic Factors in the Brains with Alzheimer's Disease - One Mechanism May Involve alpha3 Nicotinic Acetylcholine Receptor.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    June 2016
  53. TAKAHASHI R, Ishii K, Yokoyama K
    Validation of a New Imaging Technique Using the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  54. CHIARAVALLOTI A, Danieli R, Lacanfora A, Palumbo B, et al
    Usefulness of 18F Florbetaben in diagnosis of Alzheimer's disease and other types of dementia.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  55. RUB U, Stratmann K, Heinsen H, Del Turco D, et al
    The brainstem tau cytoskeletal pathology of Alzheimer`s disease: A brief historical overview and description of its anatomical distribution pattern, evolutional features, pathogenetic and clinical relevance.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  56. ALVES GS, Carvalho AF, de Amorim de Carvalho L, Sudo FK, et al
    Neuroimaging findings related to behavioral disturbances in Alzheimer's disease: a systematic review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  57. CHAKRABARTI SS, Bir A, Poddar J, Sinha M, et al
    Ceramide and sphingosine-1-phosphate in cell death pathways: Relevance to the pathogenesis of Alzheimer`s disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  58. WENZLERA S, Knochela C, Balabana C, Krafta D, et al
    Integrated biomarkers for depression in Alzheimer`s disease: a critical review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  59. PEREIRA PA, Alvim-Soares A, Bicalho MA, de Moraes EN, et al
    Lack of association between genetic polymorphism of circadian genes (PER2, PER3, CLOCK and OX2R) with late onset depression and Alzheimer's disease in a sample of a Brazilian population (Circadian Genes, Late-Onset Depression and Alzheimer's Disease).
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  60. FROST S, Guymer R, Aung KZ, Macaulay SL, et al
    Alzheimer`s disease and the early signs of age-related macular degeneration.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  61. KLIMOVA B, Kuca K
    Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer's Disease - A Mini-Review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  62. TECCHIO F, Vecchio F, Ventriglia M, Porcaro C, et al
    Non-Ceruloplasmin Copper Appears a Disctinct Subtype of Alzheimer`s Disease: A Study of EEG-Derived Brain Activity.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  63. WANG J, Zhang X, Cheng X, Cheng J, et al
    LW-AFC, a herbal medicine for Alzheimer's disease, ameliorates cognitive deterioration and modulates neuroendocrine-immune system in senescence-accelerated mouse prone 8 strain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  64. HEYMANN D, Stern Y, Cosentino S, Tatarina-Nulman O, et al
    The Association Between Alcohol Use and the Progression of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    May 2016
  65. LIU CS, Ruthirakuhan M, Chau SA, Herrmann N, et al
    Pharmacological management of agitation and aggression in Alzheimer's Disease: a review of current and novel treatments.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  66. MATURA S, Carvalho AF, Alves GS, Pantel J, et al
    Physical exercise for the treatment of neuropsychiatric disturbances in Alzheimer's dementia: possible mechanisms, current evidence and future directions.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  67. VAN DAM D, Vermeiren Y, Dekker AD, Naude PJ, et al
    Neuropsychiatric disturbances in Alzheimer's disease: what have we learned from neuropathological studies?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    April 2016
  68. MAGISTRI M, Velmeshev D, Makhmutova M, Patel P, et al
    The BET-bromodomain inhibitor JQ1 reduces inflammation and tau phosphorylation at Ser396 in the brain of the 3xTg model of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  69. SALAS-GONZALEZ D, Segovia F, Martinez-Murcia FJ, Lang EW, et al
    An Optimal Approach for Selecting Discriminant Regions for the Diagnosis of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  70. DARVESH S
    Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  71. CINZIA S, Carla P, Pietro C
    Substance P and Alzheimer's disease: emerging novel roles.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  72. QIN L, Chong T, Rodriguez R, Pugazhenthi S, et al
    Glucagon-like peptide-1-mediated modulation of inflammatory pathways in the diabetic brain: Relevance to Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  73. DIBATTISTA AM, Heinsinger NM, William Rebeck G
    Alzheimer's Disease Genetic Risk Factor APOE-epsilon4 Also Affects Normal Brain Function.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  74. ZHENG L, Duan J, Duan X, Zhou W, et al
    Association of Apolipoprotein E (ApoE) polymorphism with Alzheimer's Disease in Chinese population.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    March 2016
  75. FRINGS L, Spehl TS, Hull M, Meyer PT, et al
    Left Anterior Temporal Glucose Metabolism and not Amyloid-beta Load Predicts Naming Impairment in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  76. JI L, Zhao X, Lu W, Zhang Q, et al
    Intracellular Abeta and its Pathological Role in Alzheimer's Disease: Lessons from Cellular to Animal Models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  77. AL-BADDAI S, Neubauer A, Tome AM, Vigneron V, et al
    Functional Biomedical Images of Alzheimer's Disease a Green's Functionbased Empirical Mode Decomposition Study.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  78. FRANCOIS M, Fenech MF, Thomas P, Hor M, et al
    High content, multi-parameter analyses in buccal cells to identify Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  79. VIGNERON V, Kodewitz A, Tomeb AM, Lelandais S, et al
    Alzheimer's disease brain areas: the machine learning support for blind localization.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  80. KRASHENYI I, Ramirez J, Popov A, Gorriz JM, et al
    Fuzzy Computer-Aided Alzheimer's Disease Diagnosis Based on MRI Data.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  81. MARTINEZ-MURCIAA FJ, Gorriza JM, Ramireza J, Ortizb For The Alzheimer's Disease Neuroimaging Initiative A, et al
    A Spherical Brain Mapping of MR Images for the Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  82. BALI P, Lahiri DK, Banik A, Nehru B, et al
    Potential for Stem Cells Therapy in Alzheimer's disease: Do neurotrophic factors play critical role?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  83. REGE SD, Geetha T, Broderick TL, Babu JR, et al
    Can Diet and Physical Activity limit Alzheimer's disease Risk?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  84. MCNAMARA J, Murray TA
    Connections between Herpes Simplex Virus Type 1 and Alzheimer's Disease Pathogenesis.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  85. DORSZEWSKA J, Prendecki M, Oczkowska A, Dezor M, et al
    Molecular basis of familial and sporadic Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  86. LU W, Yang S, Zhang L, Chen L, et al
    Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  87. FISAR Z, Hroudova J, Hansikova H, Spacilova J, et al
    Mitochondrial respiration in the platelets of patients with Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  88. WEI W, Bodles-Brakhop AM, Barger SW
    A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid beta-Peptide from the Brain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    February 2016
  89. FERNANDEZ AP, Masa JS, Guedan MA, Futch HS, et al
    Adrenomedullin Expression in Alzheimer's Brain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  90. RODRIGUEZ JJ, Butt AM, Gardenal E, Parpura V, et al
    Complex and differential glial responses in Alzheimer s disease and ageing.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  91. DJORDJEVIC J, Sabbir MG, Albensi BC
    Traumatic brain injury as a risk factor for Alzheimer's disease: Is inflammatory signaling a key player?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  92. GOLDECK D, Witkowski JM, Fulop T, Pawelec G, et al
    Peripheral immune signatures in Alzheimer Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  93. MARNANE M, Hsiung GR
    Could better phenotyping small vessel disease provide new insights into Alzheimer Disease and improve clinical trial outcomes?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  94. MORRIS G, Berk M
    The Putative Use of Lithium in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  95. SUGIMOTO T, Ono R, Murata S, Saji N, et al
    Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  96. YANG KC, Chen HH
    Probabilistic cost-effectiveness analysis of vaccination for mild or moderate Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  97. GONZALEZ-DOMINGUEZ R, Ruperez FJ, Garcia-Barrera T, Barbas C, et al
    METABOLOMIC-DRIVEN ELUCIDATION OF SERUM DISTURBANCES ASSOCIATED WITH ALZHEIMER S DISEASE AND MILD COGNITIVE IMPAIRMENT.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  98. TANG Z, Liu L, Li Y, Dong J, et al
    Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer's Disease in the Transgenic CRND8 Mice.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  99. ZIYATDINOVA S, Ronnback A, Gurevicius K, Miszczuk D, et al
    Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  100. COUNTS SE, He B, Prout JG, Michalski B, et al
    Cerebrospinal fluid proNGF: A putative biomarker for early Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  101. DZAMBA D, Harantova L, Butenko O, Anderova M, et al
    Glial cells - the key elements of Alzheimer s disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  102. JI L, Zhao X, Lu W, Zhang Q, et al
    Intracellular Abeta and its pathological role in Alzheimer's disease: Lessons from cell and animal models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  103. HEAD E, Lott IT, Wilcock DM, Lemere CA, et al
    Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.
    Curr Alzheimer Res. 2016;13:18-29.
    PubMed     Text format     Abstract available


  104. POTTER H, Granic A, Caneus J
    Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:7-17.
    PubMed     Text format     Abstract available


  105. BARONE E
    Editorial: Oxidative Stress and Alzheimer Disease: Where Do We Stand?
    Curr Alzheimer Res. 2016;13:108-11.
    PubMed     Text format    


  106. CHEN Y, Yan H, Han Z, Bi Y, et al
    Functional Activity and Connectivity Differences of Five Resting-State Networks in Patients with Alzheimer's Disease or Mild Cognitive Impairment.
    Curr Alzheimer Res. 2016;13:234-42.
    PubMed     Text format     Abstract available


  107. MA J, Zhang W, Wang HF, Wang ZX, et al
    Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis.
    Curr Alzheimer Res. 2016;13:223-33.
    PubMed     Text format     Abstract available


  108. HUANG Y, Lahiri DK
    Editorial: Translational Alzheimer's Disease Research.
    Curr Alzheimer Res. 2016;13:214.
    PubMed     Text format    


  109. WEINER MW, Gorriz JM, Ramirez J, Castiglioni I, et al
    Editorial: Statistical Signal Processing in the Analysis, Characterization and Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:466-8.
    PubMed     Text format    


  110. CHOI SS, Lee SR, Lee HJ
    Neurorestorative Role of Stem Cells in Alzheimer's Disease: Astrocyte Involvement.
    Curr Alzheimer Res. 2016;13:419-27.
    PubMed     Text format     Abstract available


  111. TOLEDANO A, Merino JJ, Rodriguez JJ
    Editorial: Neuroglia in Alzheimer's Disease: From Cohort to Contestant in the Disease Progression and its Therapy.
    Curr Alzheimer Res. 2016;13:318-20.
    PubMed     Text format    


  112. MAI S
    Editorial: Towards New Approaches in Alzheimer's Research and Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:728-9.
    PubMed     Text format    


  113. DI DOMENICO F, Pupo G, Giraldo E, Lloret A, et al
    Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage.
    Curr Alzheimer Res. 2016;13:112-22.
    PubMed     Text format     Abstract available


  114. CUI YQ, Wang Q, Zhang DM, Wang JY, et al
    Triptolide Rescues Spatial Memory Deficits and Amyloid-beta Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.
    Curr Alzheimer Res. 2016;13:288-96.
    PubMed     Text format     Abstract available


  115. POLJAK A, Crawford JD, Smythe GA, Brodaty H, et al
    The Relationship Between Plasma Abeta Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study.
    Curr Alzheimer Res. 2016;13:243-55.
    PubMed     Text format     Abstract available


  116. RIVERA A, Vanzuli I, Arellano JJ, Butt A, et al
    Decreased Regenerative Capacity of Oligodendrocyte Progenitor Cells (NG2-Glia) in the Ageing Brain: A Vicious Cycle of Synaptic Dysfunction, Myelin Loss and Neuronal Disruption?
    Curr Alzheimer Res. 2016;13:413-8.
    PubMed     Text format     Abstract available


  117. HOGENAUER M, Brendel M, Delker A, Darr S, et al
    Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation.
    Curr Alzheimer Res. 2016;13:597-607.
    PubMed     Text format     Abstract available


  118. BRENDEL M, Reinisch V, Kalinowski E, Levin J, et al
    Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects.
    Curr Alzheimer Res. 2016;13:475-86.
    PubMed     Text format     Abstract available


  119. VASTA R, Augimeri A, Cerasa A, Nigro S, et al
    Hippocampal Subfield Atrophies in Converted and Not-Converted Mild Cognitive Impairments Patients by a Markov Random Fields Algorithm.
    Curr Alzheimer Res. 2016;13:566-74.
    PubMed     Text format     Abstract available


  120. WILKE C, Gillardon F, Deuschle C, Dubois E, et al
    Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease.
    Curr Alzheimer Res. 2016;13:654-62.
    PubMed     Text format     Abstract available


  121. IRWIN JA, Erisir A, Kwon I
    Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.
    Curr Alzheimer Res. 2016;13:663-77.
    PubMed     Text format     Abstract available


  122. MA C, Zhang Y, Li X, Chen Y, et al
    The TT allele of rs405509 synergizes with APOE epsilon4 in the impairment of cognition and its underlying default mode network in non-demented elderly.
    Curr Alzheimer Res. 2016;13:708-17.
    PubMed     Text format     Abstract available


  123. SALVATORE C, Battista P, Castiglioni I
    Frontiers for the Early Diagnosis of AD by Means of MRI Brain Imaging and Support Vector Machines.
    Curr Alzheimer Res. 2016;13:509-33.
    PubMed     Text format     Abstract available


  124. GALLIVANONE F, Della Rosa PA, Castiglioni I
    Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD.
    Curr Alzheimer Res. 2016;13:682-94.
    PubMed     Text format     Abstract available


    December 2015
  125. BECK JS, Mufson EJ, Counts SE
    Evidence for mitochondrial UPR gene activation in familial and sporadic Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  126. XU J, Xia LL, Song N, Chen SD, et al
    Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer's Disease: A Meta-Analysis.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  127. VICKERS JC, Woodhouse A, Fernandez-Martos CM, Kirkcaldie MT, et al
    Defining the earliest pathological changes of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  128. BU XL, Jiao SS, Lian Y, Wang YJ, et al
    Perspectives on the tertiary prevention strategy for Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    November 2015
  129. ESTERAS N, Alquezar C, de la Encarnacion A, Martin-Requero A, et al
    Lymphocytes in Alzheimer's disease pathology: Altered signaling pathways.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  130. TEJERA D, Heneka MT
    Microglia in Alzheimer's disease: the good, the bad and the ugly.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  131. BERGERON D, Bensaidane R, Laforce R Jr
    Untangling Alzheimer's disease clinicoanatomical heterogeneity through selective network vulnerability - an effort to understand a complex disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  132. BESGA-BASTERRA A, Chyzhyk D, Gonzalez-Ortega I, Savio A, et al
    Eigenanatomy on fractional anisotropy imaging provides white matter anatomical features discriminating between Alzheimer's Disease and Late Onset Bipolar Disorder.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  133. MERINO JJ, Muneton-Gomez V, Alvarez MI, Toledano-Diaz A, et al
    Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-Tau accumulation in Alzheimer,s disease (AD) rodent models: Is fractalkine a systemic biomarker for AD?
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  134. LIM D, Rodriguez-Arellano JJ, Parpura V, Zorec R, et al
    Calcium signalling toolkits in astrocytes and spatio-temporal progression of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  135. CARMONA P, Molina M, Toledano A
    Blood-based biomarkers of Alzheimer s disease: diagnostic algorithms and new technologies.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  136. TOLEDANO A, Alvarez MI, Toledano-Diaz A, Merino JJ, et al
    Brain local and regional neuroglial alterations in Alzheimer s Disease: cell types, responses and implications.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  137. SU L, Blamire AM, Watson R, He J, et al
    Cortical and subcortical changes in Alzheimer's disease: a longitudinal and quantitative MRI study.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  138. SEGOVIA F, G'orriz JM, Ram'irez J, Phillips C, et al
    Combining feature extraction methods to assist the diagnosis of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  139. MARTINEZ-MURCIA FJ, Gorriz JM, Ramirez J, Ortiz A, et al
    A Statistical Projection of MRI Brain Images for the Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  140. ZIPPO AG, Castiglioni I
    Integration of 18FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    October 2015
  141. HERRAN E, Perez-Gonzalez R, Igartua M, Pedraz JL, et al
    Enhanced hippocampal neurogenesis in APP/Ps1 mouse model of Alzheimer's disease after implantation of VEGF-loaded PLGA nanospheres.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  142. KARA F, Hofling C, Rossner S, Schliebs R, et al
    In vivo longitudinal monitoring of changes in the corpus callosum integrity during disease progression in a mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  143. RASMUSSEN L, Delabio R, Viani GA, Chen E, et al
    Differential Expression of Ribosomal Genes in Brain and Blood of Alzheimer's Disease Patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  144. ZIVKOVIC L, Bajic V, Perry G, Spremo-Potparevica B, et al
    Alterations of the X Chromosome in Lymphocytes of Alzheimer's Disease Patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  145. LIN TW, Liu YF, Shih HS, Chen SJ, et al
    Neurodegeneration in amygdala precedes hippocampus in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  146. WIESMANN M, Capone C, Zerbi V, Mellendijk L, et al
    Hypertension impairs cerebral blood flow in a mouse model for Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  147. BOIOCCHI C, Maggioli E, Monti MC, Zorzetto M, et al
    The Possible Involved of HLA Class III Haplotype (RAGE, HSP70 and TNF Genes) in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  148. SALEHI A, Ashford JW, Mufson EJ
    Editorial: The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.
    Curr Alzheimer Res. 2015.
    PubMed     Text format    


    September 2015
  149. HAMLETT E, Boger HA, Ledreux A, Kelley CM, et al
    Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  150. PHILLIPS C, Fahimi A, Das D, Mojabi FS, et al
    Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  151. IULITA MF, Claudio Cuello CA
    The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  152. STRUPP BJ, Powers BE, Velazquez R, Ash JA, et al
    Maternal choline supplementation:A potential prenatal treatment for Down syndrome and Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  153. SERINI S, Calviello G
    Reduction of oxidative/nitrosative stress in brain and its involvement in the neuroprotective effect of n-3 PUFA in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  154. LLORET A, Fuchsberger T, Giraldo E, Vina J, et al
    Reductive stress: A new concept in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  155. GIUDETTI AM, Romano A, Lavecchia AM, Gaetani S, et al
    The role of brain cholesterol and its oxidized products in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    July 2015
  156. COUPLAND KG, Kim WS, Halliday GM, Hallupp M, et al
    Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  157. INEKCI D, Henriksen K, Linemann T, Karsdal MA, et al
    Serum fragments of Tau for the differential diagnosis of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  158. BEAUCHET O, Cp L, Montero-Odasso M, Annweiler C, et al
    Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  159. SUI X, Zhu M, Cui Y, Yu C, et al
    Functional connectivity hubs could serve as a potential biomarker in Alzheimer's disease: a reproducible study.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  160. CHENG XR, Cui XL, Zheng Y, Zhang GR, et al
    A co-module regulated by therapeutic drugs in a molecular subnetwork of Alzheimer's disease identified on the basis of traditional Chinese medicine and SAMP8 mice.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  161. EL HAJ M, Raffard S, Antoine P, Gely-Nargeot MC, et al
    Emotion and destination memory in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  162. PLAGG B, Ehrlich D, Kniewallner KM, Marksteiner J, et al
    Increased acetylation of histone H4 at lysine 12 (H4K12) in monocytes of transgenic Alzheimer's mice and in human patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  163. FERRARI R, Ferrara M, Alinani A, Sutton RB, et al
    Screening of Early and Late Onset Alzheimer's Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  164. NUZZO D, Picone P, Baldassano S, Caruana L, et al
    Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  165. ZHANG Y, Wang F, Luo X, Wang L, et al
    Cognitive improvement by photic stimulation in a mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  166. VOLGYI K, Juhasz G, Kovacs Z, Penke B, et al
    Dysfunction of Endoplasmic Reticulum (ER) and Mitochondria (MT) in Alzheimer's Disease: The Role of the ER-MT Cross-Talk.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  167. WALDRON A, Wyffels L, Verhaeghe J, Bottelbergs A, et al
    Quantitative muPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  168. YASUE M, Sugiura S, Uchida Y, Otake H, et al
    Prevalence of Sinusitis Detected by Magnetic Resonance Imaging in Subjects with Dementia or Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    May 2015
  169. CM K, Jh W, Jm L, Jh R, et al
    Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  170. Q Z, Q G, X L, M C, et al
    Auditory Verbal Learning Test is Superior to Rey-Osterrieth Complex Figure Memory for Predicting Mild Cognitive Impairment to Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  171. B Z
    Prevention strategies targeting different preclinical stages of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  172. PATEL V, Zhang X, Tautiva NA, Nyabera AN, et al
    Small Molecules And Alzheimer's Disease: Misfolding, Metabolism And Imaging.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  173. ZHAI P, Xia CL, Tan JH, Li D, et al
    Syntheses and Evaluation of Asymmetric Curcumin Analogues as Potential Multifunctional Agents for the Treatment of Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    March 2015
  174. ZHOU R, Liu D, Yu K, Chen Y, et al
    Carotid and vertebral arterial variations in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  175. ABDEL MONEIM AE
    Oxidant/antioxidant imbalance and the risk of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  176. BRAIDY N, Zarka M, Welch J, Bridge W, et al
    Therapeutic Approaches to ModulatingGlutathione Levels as a Pharmacological strategy in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  177. CLERX L, Gronenschild HB, Echavarri C, Verhey F, et al
    Can Free Surfer compete with manual volumetricmeasurements in Alzheimer's disease?
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  178. ARAI H, Suzuki H, Yoshiyama T
    Vanutide Cridificar and the QS-21 Adjuvant in Japanese Subjects With Mild to Moderate Alzheimer's Disease: Results from Two Phase 2 Studies.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  179. ARAI H, Suzuki H, Yoshiyama T, Luckhoff HK, et al
    Clinical relevance of apolipoprotein E genotyping based on a family history of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  180. LEIFERT WR, Ferdoush Tuli J, Francois M, Nguyen T, et al
    Buccal cell cytokeratin 14 identifies mild cognitive impairment and Alzheimer's disease in the AIBL study of aging.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  181. HU X, Meiberth D, Newport B, Jessen F, et al
    Anatomical Correlates of the Neuropsychiatric Symptoms in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  182. JIANG S, Yang W, Qiu Y, Chen HZ, et al
    Identification of Novel Quantitative Traits-associated Susceptibility Loci for APOE epsilon4 non-carriers of Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  183. BRAIDY N, Zarka M, Welch J, Bridge W, et al
    Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological strategy in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    February 2015
  184. YEGAMBARAM M, Manivannan B, Beach TG, Halden RU, et al
    Role of Environmental Contaminants in the Etiology of Alzheimer's Disease: A Review.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  185. CHI S, Wang C, Jiang T, Zhu XC, et al
    The Prevalence of Depression in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  186. MONTEIRO-CARDOSO VF, Castro M, Oliveira MM, Moreira PI, et al
    Age-Dependent Biochemical Dysfunction in Skeletal Muscle of Triple- Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  187. CHATTERJEE P, Gupta VB, Fagan AM, Jasielec MS, et al
    Decreased Platelet APP Isoform Ratios in Autosomal Dominant Alzheimer's Disease: Baseline Data from a DIAN Cohort Subset.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  188. TING WK, Fischer CE, Millikin CP, Ismail Z, et al
    Grey Matter Atrophy in Mild Cognitive Impairment / Early Alzheimer Disease Associated with Delusions: A Voxel-Based Morphometry Study.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    January 2015
  189. YANG P, Xu M, Liu Z, Tao Q, et al
    Genetic Association of CUGBP2 and DNMBP with Alzheimer' s Disease in the Chinese Han Population.
    Curr Alzheimer Res. 2015;12:228-32.
    PubMed     Text format     Abstract available


  190. JEONG YJ, Kang GY, Kwon JH, Choi HD, et al
    1950 MHz Electromagnetic Fields Ameliorate Abeta Pathology in Alzheimer's Disease Mice.
    Curr Alzheimer Res. 2015;12:481-92.
    PubMed     Text format     Abstract available


  191. DEZSI L, Tuka B, Martos D, Vecsei L, et al
    Alzheimer's disease, astrocytes and kynurenines.
    Curr Alzheimer Res. 2015;12:462-80.
    PubMed     Text format     Abstract available


  192. MA DL, Leung CH
    Editorial: small molecule therapeutics for Alzheimer's disease.
    Curr Alzheimer Res. 2015;12:400-2.
    PubMed     Text format    


  193. RASKIN J, Cummings J, Hardy J, Schuh K, et al
    Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions.
    Curr Alzheimer Res. 2015;12:712-22.
    PubMed     Text format     Abstract available


  194. MARESOVA P, Mohelska H, Dolejs J, Kuca K, et al
    Socio-economic Aspects of Alzheimer's Disease.
    Curr Alzheimer Res. 2015;12:903-11.
    PubMed     Text format     Abstract available


  195. LAHIRI DK
    View of excellent ROAD from the CAR.
    Curr Alzheimer Res. 2015;12:96-9.
    PubMed     Text format    


  196. ZHANG Y, Zou J, Yang J, Yao Z, et al
    4Abeta1-15-Derived Monoclonal Antibody Reduces More Abeta Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice.
    Curr Alzheimer Res. 2015;12:384-97.
    PubMed     Text format     Abstract available


  197. CHAO F, Zhang L, Luo Y, Xiao Q, et al
    Running Exercise Reduces Myelinated Fiber Loss in the Dentate Gyrus of the Hippocampus in APP/PS1 Transgenic Mice.
    Curr Alzheimer Res. 2015;12:377-83.
    PubMed     Text format     Abstract available


  198. ANTES R, Salomon-Zimri S, Beck SC, Garcia Garrido M, et al
    VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina.
    Curr Alzheimer Res. 2015;12:323-34.
    PubMed     Text format     Abstract available


  199. DEACON RM, Altimiras FJ, Bazan-Leon EA, Pyarasani RD, et al
    Natural AD-Like Neuropathology in Octodon degus: Impaired Burrowing and Neuroinflammation.
    Curr Alzheimer Res. 2015;12:314-22.
    PubMed     Text format     Abstract available


  200. WONG CY, Chung LH, Lu L, Wang M, et al
    Dual Inhibition And Monitoring Of Beta-amyloid Fibrillation By A Luminescent Iridium(III) Complex.
    Curr Alzheimer Res. 2015;12:439-44.
    PubMed     Text format     Abstract available


  201. KOCHI A, Lee HJ, Vithanarachchi SM, Padmini V, et al
    Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-beta Aggregation.
    Curr Alzheimer Res. 2015;12:415-23.
    PubMed     Text format     Abstract available


    December 2014
  202. GROSSBERG GT, Farlow MR, Meng X, Velting DM, et al
    Evaluating High-Dose Rivastigmine Patch in Severe Alzheimer's Disease: Analyses with Concomitant Memantine Usage as a Factor.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  203. MATEJ R, Rohan Z, Holada K, Olejar T, et al
    The Contribution of Proteinase-Activated Receptors to Intracellular Signaling, Transcellular Transport and Autophagy in Alzheimer s Disease.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  204. HALL A, Mattila J, Koikkalainen J, Lotjonen J, et al
    Predicting Progression from Cognitive Impairment to Alzheimer's Disease with the Disease State Index.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  205. ZHOU W, Li X, Huang D, Zhou W, et al
    No Significant Effect of 7,8-Dihydroxyflavone on APP Processing and Alzheimer-Associated Phenotypes.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  206. DEVI L, Tang J, Ohno M
    Beneficial Effects of the beta-Secretase Inhibitor GRL-8234 in 5XFAD Alzheimer's Transgenic Mice Lessen during Disease Progression.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  207. BARANELLO RJ, Bharani KL, Padmaraju V, Chopra N, et al
    Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer's Disease.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  208. SCHROTT LM, Jackson K, Yi P, Dietz F, et al
    Acute Oral Bryostatin-1 Administration Improves Learning Deficits in the APP/PS1 Transgenic Mouse Model of Alzheimer's Tg Mice.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  209. WANG D, Guo Z, Liu X, Li YH, et al
    Examination of Hippocampal differences between Alzheimer Disease, Amnestic Mild Cognitive Impairment and Normal Aging: Diffusion kurtosis.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  210. CHEN H, Liu S, Ji L, Wu T, et al
    Associations between Alzheimer's Disease and Blood Homocysteine, Vitamin B12, and Folate: A Case-Control Study.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


    November 2014
  211. FAWVER JN, Ghiwot Y, Koola C, Carrera W, et al
    Islet Amyloid Polypeptide (IAPP): a Second Amyloid in Alzheimer's Disease.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  212. YANG W, Chauhan A, Wegiel J, Kuchna I, et al
    Effect of Trichostatin A on Gelsolin Levels, Proteolysis of Amyloid Precursor Protein, and Amyloid Beta-Protein Load in the Brain of Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  213. TIAOTIAO LI, Wenwen B, Hu Y, Tan T, et al
    Functional Connectivity in a Rat Model of Alzheimer's Disease during a Working Memory Task.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  214. MRAVEC B, Lejavova K, Cubinkova V
    Locus (coeruleus) Minoris Resistentiae in Pathogenesis of Alzheimer's Disease.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


  215. ALBERICI A, Benussi A, Premi E, Borroni B, et al
    Clinical, Genetic, and Neuroimaging Features of Early Onset Alzheimer Disease: the Challenges of Diagnosis and Treatment.
    Curr Alzheimer Res. 2014.
    PubMed     Text format     Abstract available


    March 2014
  216. ZHANG YH, Mann D, Raymick J, Sarkar S, et al
    K114 inhibits A-beta aggregation and inflammation in vitro and in vivo in AD/Tg mice.
    Curr Alzheimer Res. 2014;11:299-308.
    PubMed     Text format     Abstract available


    February 2014
  217. HERNANDEZ I, Mauleon A, Rosense-Roca M, Alegret M, et al
    Identification of misdiagnosed fronto-temporal dementia using APOE genotype and phenotype-genotype correlation analyses.
    Curr Alzheimer Res. 2014;11:182-91.
    PubMed     Text format     Abstract available


    January 2014
  218. RANDRIAMBOAVONJY V, Sopova K, Stellos K, Laske C, et al
    Platelets as potential link between diabetes and Alzheimer's disease.
    Curr Alzheimer Res. 2014;11:862-8.
    PubMed     Text format     Abstract available


  219. MACDONALD IR, DeBay DR, Reid GA, O'Leary TP, et al
    Early detection of cerebral glucose uptake changes in the 5XFAD mouse.
    Curr Alzheimer Res. 2014;11:450-60.
    PubMed     Text format     Abstract available


  220. LV C, Liu X, Liu H, Chen T, et al
    Geniposide attenuates mitochondrial dysfunction and memory deficits in APP/PS1 transgenic mice.
    Curr Alzheimer Res. 2014;11:580-7.
    PubMed     Text format     Abstract available


  221. ALBERT M, Soldan A, Gottesman R, McKhann G, et al
    Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.
    Curr Alzheimer Res. 2014;11:773-84.
    PubMed     Text format     Abstract available


  222. WAKEFIELD SJ, McGeown WJ, Shanks MF, Venneri A, et al
    Differentiating normal from pathological brain ageing using standard neuropsychological tests.
    Curr Alzheimer Res. 2014;11:765-72.
    PubMed     Text format     Abstract available


  223. WANG J, Zhang Y, Xu H, Zhu S, et al
    Fluoxetine improves behavioral performance by suppressing the production of soluble beta-amyloid in APP/PS1 mice.
    Curr Alzheimer Res. 2014;11:672-80.
    PubMed     Text format     Abstract available


  224. IYER AM, van Scheppingen J, Milenkovic I, Anink JJ, et al
    Metabotropic glutamate receptor 5 in Down's syndrome hippocampus during development: increased expression in astrocytes.
    Curr Alzheimer Res. 2014;11:694-705.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: